{"prompt": "['Date and version No: FUTUREGB_Protocol_V6.0_19Jan2022.doc', 'Objectives', 'Outcome Measures', 'Timepoint(s)', 'Secondary', 'To assess whether additional', 'PFS (time from randomisation', 'MRI at 6 months post-', 'intraoperative imaging (DTI and iUS*)', 'to radiological tumour', 'surgery and then', 'to standard of care (neuronavigation', 'progression on imaging, as', '3mthly up to 24 months', 'based on preoperative MRI scan and', 'agreed in local MDT).', 'or an MRI performed', 'intraoperative 5-ALA) improves', 'outside protocol if', 'Progression Free Survival (PFS)', 'patient is symptomatic.', 'Secondary', 'To assess whether additional', 'Extent of resection as % of pre-', 'Post-operative review', 'intraoperative imaging (DTI and iUS*)', 'operative tumour volume on', 'to standard of care (neuronavigation', 'postoperative contrast', 'based on preoperative MRI scan and', 'enhanced MRI', 'intraoperative 5-ALA) improves the', 'extent of tumour resection', 'Secondary', 'To assess whether additional', 'Number and type of surgical', '5 days post-op., or', 'intraoperative imaging (DTI and iUS*)', 'complications', 'discharge date', 'to standard of care (neuronavigation', '(whichever is soonest);', 'based on preoperative MRI scan and', '6wks post-op.,3mths', 'intraoperative 5-ALA) improves the', 'post op., and then', 'incidence of surgical complications', '3mthly up to 24 months', 'Secondary', 'To assess whether additional', 'Number of patients eligible for', '3mths post-op.', 'intraoperative imaging (DTI and iUS*)', 'adjuvant treatment', 'to standard of care (neuronavigation', 'based on preoperative MRI scan and', 'intraoperative 5-ALA) improves the', 'number of patients eligible for', 'adjuvant treatment following surgery', 'Secondary', 'To assess whether additional', 'WHO performance status', 'Baseline, 5 days post-', 'intraoperative imaging (DTI and iUS*)', 'mini-MoCA (Montreal Version)', 'op., or discharge date', 'to standard of care (neuronavigation', 'Barthel Index', '(whichever is soonest);', 'based on preoperative MRI scan and', 'MRC grading of power in all 4', '6wks post-op.,3mths', 'intraoperative 5-ALA) improves the', 'limbs', 'post op. and then', 'functional outcome postoperatively', '3mthly up to 24 months', '(MRC grading at', 'baseline and 5 days', 'post-op., or discharge', 'date (whichever is', 'soonest) only)', 'Secondary', 'Assess the correlation of proxy to', 'At a minimum, answers to', 'Baseline, 6wks post op,', 'participant classification assessment', 'questions 29 and 30 of the', '3mths post op. and', 'of quality of life', 'QLQ-C30. Ideally answers will', 'then 3mthly up to 24', 'months.', 'Clinical Research Protocol Template version 14.0', 'Page 24 of 65', 'C Copyright: The University of Oxford and Oxford University Hospitals NHS Foundation Trust 2018', 'CONFIDENTIAL']['Date and version No: FUTUREGB_Protocol_V6.0_19Jan2022.docr', 'Objectives', 'Outcome Measures', 'Timepoint(s)', 'be provided to all of the QLQ-', 'C30 and BN20.', 'Tertiary -', 'Sensitivity and specificity of the', 'Sensitivity and specificity', 'Analysis will be', 'Mechanistic', 'anatomico-spatial location of DTI', 'calculation using pre and post-', 'undertaken post-', 'Study Objectives', 'fibre tracts compared with', 'surgery MRI images', 'surgery.', '- on a sub-set of', 'intraoperative direct electrical', 'participants', 'stimulation/behavioural change', 'without stimulation but related to', 'adjacent white fibre tract in patients', 'undergoing awake surgery, or motor', 'evoked potential changes in patients', 'undergoing surgery.', 'Tertiary -', 'Sensitivity and specificity of iUS* to', 'Intra operative iUS* images', 'Analysis will be', 'Mechanistic', 'identify the tumour boundary when', 'and post-operative MRI scans', 'undertaken post-', 'Study Objectives', 'compared with 5-ALA and post-', 'and Intraoperative biopsy', 'surgery when biopsy', '- on a sub-set of', 'operative MRI scan. Navigated', 'samples', 'results are available.', 'participants', 'biopsies will be taken from tumour', 'boundary tissue planned for', 'resection.', '7. STUDY DESIGN', '7.1. Stage 1: non-randomised multicentre learning and evaluation stage (IDEAL Stage IIB', 'study)', 'This is a non-randomised multicentre learning and harmonisation stage in which quality control', 'measures and mentoring will be employed to improve and evaluate standards of practice (IDEAL Stage', 'IIB Study). 50,51 The IDEAL Stage IIB study will determine whether surgeons using the technologies', 'employed in the randomised controlled trial demonstrate acceptable expertise in delivering the new', 'approach prior to proceeding with the randomisation stage.', 'Stage 1 is divided into 3 components:', '1. Pre-trial Webinar (see section 9.1.1)', '2. IDEAL Stage IIB (Quality assurance, Mentoring and Trial centres evaluation) (see section 9.1.2)', '3. End of Stage 1, Pre-Stage 2 RCT, each participating centre will have a data workflow review', '(Appendices C-E) with the Lead Investigators to review the cases completed in Stage 1.', 'The IDEAL Stage IIB study will comprise the following:', 'Clinical Research Protocol Template version 14.0', 'Page 25 of 65', 'C Copyright: The University of Oxford and Oxford University Hospitals NHS Foundation Trust 2018', 'CONFIDENTIAL']\n\n###\n\n", "completion": "END"}